Steve Mahoney
President and Chief Executive Officer @ Viridian Therapeutics
About Steve Mahoney
Steve Mahoney is the President and CEO with a diverse background in biopharmaceuticals and law, holding degrees from Boston College and Colorado College.
Known information
Steve Mahoney serves as the President and Chief Executive Officer, bringing a robust educational background with a Master’s in Business Administration from Boston College’s Carroll School of Management and a Juris Doctor from Boston College Law School. He also holds a Bachelor of Arts from Colorado College. Mahoney’s career spans significant roles in the biopharmaceutical industry, including as Chief Financial and Operating Officer of Magenta Therapeutics and President and Chief Operating Officer at Kiniksa Pharmaceuticals, a company he helped found. Earlier, he was the Chief Commercial Officer at Synageva Biopharma and spent about ten years as a commercial attorney at Genzyme Corporation. He began his career as a corporate attorney with Mintz Levin. Additionally, he serves on the board of directors of Vesselon, Inc.
About Viridian Therapeutics
Viridian Therapeutics is a biotechnology company focused on developing innovative medicines for autoimmune and rare diseases, with a strong emphasis on thyroid eye disease.